Safety and efficacy of FOLFOX plus bevacizumab or FOLFIRI plus bevacizumab as second line Therapy in Advanced colorectal Cancer previously treated with bevacizumab.
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2617856
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: FOLFOX plus bevacizumab or FOLFIRI plus bevacizumab is treated until progression.
Primary outcome(s): progression free survival
Study Design: Single arm Non-randomized
创建时间：
2009-01-15
